So I take from this:
• trial met its main endpoint of safety - tick
• three quarters received steroids which likely account for most of the perceived benefit eg the CRP change
• nothing really convincing here that Nox drug provided therapeutic benefit, which Nox acknowledges in stating controlled trial will be needed
• they think it’s good enough to take into a larger trial but will need to join one of the large adaptive trials like Recovery
• if they can piggy back an existing platform like Recovey, good luck
and of course RBx predictably starts new thread and calls this a wonder drug!!
- Forums
- ASX - By Stock
- Ann: NOXCOVID Program to Expand After Positive Phase 1 Results
So I take from this:• trial met its main endpoint of safety -...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
7.0¢ |
Change
0.003(4.48%) |
Mkt cap ! $20.45M |
Open | High | Low | Value | Volume |
6.6¢ | 7.0¢ | 6.6¢ | $3.77K | 54.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 45399 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 0.066 |
1 | 30539 | 0.065 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
2 | 31393 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 45399 | 1 |
0.075 | 16806 | 1 |
0.079 | 10000 | 1 |
0.081 | 12345 | 1 |
0.083 | 40000 | 1 |
Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online